What the rule is about
Each weekly label ties the injection to a fixed weekday, then adds one sentence about moving that day if needed. The sentence does not describe a new dose or a different amount. It sets a single condition: enough time must have passed since the previous injection.
That makes the rule a question about hours, not weekdays. Two shots on “Sunday” and “Tuesday” can be 40 hours apart or 60, depending on the time of day, and only the exact times tell you which side of the line you are on.
The minimum gap in each document
The table sets the US wording next to the European or Canadian one for each medicine. It summarises the documents for comparison; the leaflet in your own pack, and what your prescriber has told you, are what apply to you.
| Medicine | US label | EU or Canadian document |
|---|---|---|
| Ozempic® injection, semaglutide [1] | Section 2.1: at least 2 days (more than 48 hours) between the two doses. Medication Guide: last dose 2 or more days before | EU SmPC 4.2: at least 3 days (more than 72 hours) [10] |
| Wegovy® injection, semaglutide [2] | No day-change sentence in section 2; the Medication Guide allows a move once the last dose was 2 or more days before | EU SmPC 4.2: at least 3 days (more than 72 hours) [11] |
| Mounjaro®, tirzepatide [3] | Section 2.1: the two doses kept at least 3 days (72 hours) apart | EU SmPC 4.2: at least 3 days [12]; Canadian monograph 4.5: the same 72 hours [15] |
| Zepbound®, tirzepatide [4] | Section 2.3: the two doses kept at least 3 days (72 hours) apart | Canadian monograph 4.4: the same 72 hours [14]; no EU product information under this name |
| Trulicity®, dulaglutide [5] | Section 2.3: last dose given 3 or more days before the new day | EU SmPC 4.2: last dose 3 or more days (72 hours) before [13] |
| Saxenda® and Victoza®, liraglutide [6][7] | Once daily at any time of day; no dose adjustment when timing or site changes (Saxenda® 2.1, Victoza® 2.3) | No weekly day to move |
| Wegovy®, Rybelsus® and Ozempic® tablets; Foundayo™ [2][8][9] | Once daily: semaglutide tablets in the morning on an empty stomach (Wegovy® 2.1, Rybelsus® 2.1); Foundayo™ with or without food (2.1) | No weekly day to move |
Counting the gap
Start from the date and time of your last injection, not from the day you meant to take it. Suppose your last dose was on Sunday at 8 pm. Wednesday at 8 pm is exactly 72 hours later: it meets the 3-day rule in the US Mounjaro®, Zepbound® and Trulicity® labels, but the EU Ozempic® and Wegovy® documents ask for more than 72 hours, so it sits right on their line [3][4][5][10][11]. Tuesday at 8 pm is exactly 48 hours later, on the edge for the US Ozempic® label, which asks for more than 48 hours, and short of every 3-day rule [1]. Tuesday morning is under 48 hours and meets none of them.
Moving the day later works differently: the gap simply stretches past a week. The day-change sentences only set a minimum, so they do not say how long a stretch is acceptable. A late injection is covered by each label’s missed-dose section, which allows 5 days for Ozempic® and 4 days for Mounjaro® and Zepbound® [1][3][4]. If a later day would push you beyond that window, it is worth asking your pharmacist first.
Why the US and EU numbers differ
Product information is written and approved separately by each regulator, and the documents do not explain why their minimums differ. For Ozempic® and Wegovy®, the practical result is a one-day difference: the US texts are satisfied once more than 48 hours, or 2 days, have passed, while the EU texts wait for more than 72 hours [1][2][10][11]. For tirzepatide and dulaglutide, the US, EU and Canadian documents agree on 3 days [3][4][5][12][13][14][15].
The wording that applies to you is the one in the leaflet that came with your medicine. If you fill prescriptions in more than one country, or travel with a pack bought elsewhere, the two texts can disagree; your pharmacist can tell you which one your pack carries.
Moving earlier or later
- Earlier in the week: the gap since the last dose shrinks, so this is where the 2-day or 3-day minimum matters.
- Later in the week: the gap grows, so the minimum is not the problem, but one interval becomes longer than seven days and the missed-dose window becomes the relevant limit.
- Both directions: once the move is made, the weekly rhythm carries on from the new day; the EU Ozempic® and Wegovy® documents say so in as many words [10][11].
- If you are unsure which direction suits your situation, that is a quick question for your prescriber or pharmacist.
What the move does not change
None of the day-change sentences mentions changing the dose. The Wegovy® label states that the time of day and the injection site can change without a dosage modification, and the Saxenda® and Victoza® labels say no dose adjustment is needed when the timing or site changes [2][6][7]. Decisions about the dose itself stay with your prescriber.
Other label rules carry on as before: rotating the injection site with each dose, and the limits on how long an opened pen or multi-dose vial may be used. Those limits are counted from first use, and for some multi-dose presentations by the number of doses, not by weekday, so moving the day does not reset them.
When a move is often needed
The most common reason is travel, especially across time zones, where the local weekday and the hours since your last dose can drift apart. A new work rota or an event that falls on shot day are others.
A planned operation or a procedure under sedation is a separate case. The labels ask you to tell the healthcare team beforehand that you take the medicine, because it can slow stomach emptying [1][2][3][4]. Whether a dose should move around the procedure is for that team and your prescriber to decide, not something the day-change rule settles.
Before you move the day
- The exact date and time of the last dose you actually took.
- The product and the country the leaflet in your pack comes from, since the minimum can differ.
- The new day and time you have in mind, and the hours that leaves between the two doses.
- Any planned procedure, trip or change of rota that the move is meant to fit around.
Ozempic®, Wegovy®, Rybelsus®, Saxenda® and Victoza® are registered trademarks of Novo Nordisk A/S. Mounjaro®, Zepbound® and Trulicity® are registered trademarks and Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company.
